Research ArticleClinical Studies
Phase I Study of Combination Therapy With Weekly Nanoparticle Albumin-bound Paclitaxel and Cyclophosphamide in Metastatic Breast Cancer Patients
DAISUKE OTA, SOTARO AKATSUKA, TSUNEHIRO NISHI, TAKAO KATO, MASASHI TAKEUCHI, MUNECHIKA TSUJI and ATSUSHI FUKUUCHI
Anticancer Research December 2019, 39 (12) 6903-6907; DOI: https://doi.org/10.21873/anticanres.13910
DAISUKE OTA
1Department of Breast and Endocrine Surgery, Mitsui Memorial Hospital, Tokyo, Japan
SOTARO AKATSUKA
2Department of Medical Oncology, Mitsui Memorial Hospital, Tokyo, Japan
TSUNEHIRO NISHI
1Department of Breast and Endocrine Surgery, Mitsui Memorial Hospital, Tokyo, Japan
TAKAO KATO
1Department of Breast and Endocrine Surgery, Mitsui Memorial Hospital, Tokyo, Japan
MASASHI TAKEUCHI
1Department of Breast and Endocrine Surgery, Mitsui Memorial Hospital, Tokyo, Japan
MUNECHIKA TSUJI
1Department of Breast and Endocrine Surgery, Mitsui Memorial Hospital, Tokyo, Japan
ATSUSHI FUKUUCHI
1Department of Breast and Endocrine Surgery, Mitsui Memorial Hospital, Tokyo, Japan
In this issue
Anticancer Research
Vol. 39, Issue 12
December 2019
Phase I Study of Combination Therapy With Weekly Nanoparticle Albumin-bound Paclitaxel and Cyclophosphamide in Metastatic Breast Cancer Patients
DAISUKE OTA, SOTARO AKATSUKA, TSUNEHIRO NISHI, TAKAO KATO, MASASHI TAKEUCHI, MUNECHIKA TSUJI, ATSUSHI FUKUUCHI
Anticancer Research Dec 2019, 39 (12) 6903-6907; DOI: 10.21873/anticanres.13910
Phase I Study of Combination Therapy With Weekly Nanoparticle Albumin-bound Paclitaxel and Cyclophosphamide in Metastatic Breast Cancer Patients
DAISUKE OTA, SOTARO AKATSUKA, TSUNEHIRO NISHI, TAKAO KATO, MASASHI TAKEUCHI, MUNECHIKA TSUJI, ATSUSHI FUKUUCHI
Anticancer Research Dec 2019, 39 (12) 6903-6907; DOI: 10.21873/anticanres.13910
Jump to section
Related Articles
Cited By...
- No citing articles found.








